Charles River Laboratories International (CRL) Non-Current Debt (2009 - 2025)

Charles River Laboratories International's Non-Current Debt history runs 17 years deep, the most recent figure standing at $2.1 billion for Q4 2025.

• In Q4 2025, Non-Current Debt fell 4.64% year-over-year to $2.1 billion; the TTM figure through Dec 2025 stood at $2.1 billion (down 4.64% YoY), while the FY2025 annual figure was $2.1 billion, down 4.64% from the prior year.
• Non-Current Debt was $2.1 billion for Q4 2025 at Charles River Laboratories International, down from $2.2 billion in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $3.0 billion in Q2 2022 to a low of $2.1 billion in Q4 2025.
• Historically, Non-Current Debt has averaged $2.6 billion across 5 years, with a median of $2.7 billion in 2023.
• The sharpest annual moves came in 2021 and 2024: Non-Current Debt soared 38.04% in 2021, then declined 15.37% in 2024.
• A 5-year view of Non-Current Debt shows it stood at $2.7 billion in 2021, then advanced by 1.65% to $2.7 billion in 2022, then dropped by 2.23% to $2.6 billion in 2023, then fell by 15.37% to $2.2 billion in 2024, then slipped by 4.64% to $2.1 billion in 2025.
• The last three Non-Current Debt figures came in at $2.1 billion (Q4 2025), $2.2 billion (Q3 2025), and $2.3 billion (Q2 2025), per Business Quant data.